comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-28 20:31:59 - browse：9

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

WSS

Timeline: Special counsel's probe into Trump's handling of classified documents

Eyeing GLP

Ford recalls 870K F

Ending health disparities requires full federal government, panel says

The mammogram wars are not over

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

explore

comprehensive

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Scrutiny of post

Alkermes shareholders re

McConnell had minor fall 2 weeks ago, uses wheelchair periodically to get around: Sources

Medical leaders decry Supreme Court decision on affirmative action

ASCO eve: Let’s set the table for this year's meeting

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The mammogram wars are not over

Malaria cases in Florida and Texas: Here’s what you need to know

Investigation reveals sickle cell patients pressured into sterilizations

focus

Digital health: a case of mistaken identity

As the dark side of IVF slowly comes into focus, even more transparency is needed

Reports of telehealth's death have been greatly exaggerated

Citing H5N1 threat, CDC urges peak flu monitoring this summer

Bird flu surveillance in wastewater gets boost from consortium

Listen: More tumult at BIO & coercive care for sickle cell patients

leisure time

focus

hotspot

hotspot